{"timestamp": 1771600257.8714132, "value": {"ticker": "ERNA", "company_name": "Ernexa Therapeutics Inc.", "short_name": "Ernexa Therapeutics Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 9944200, "float_shares": 6485223, "shares_outstanding": 29085114, "short_ratio": 0.45, "short_percent_of_float": 0.0209, "shares_short": 134358, "shares_short_prior": 105975, "insider_percent_held": 0.31834, "institution_percent_held": 0.01812, "total_cash": 3047000, "total_debt": 552000, "total_revenue": 1000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -9922.0, "debt_to_equity": 15.462, "current_ratio": 1.576, "book_value": 0.455, "price_to_book": 0.75142854, "operating_cashflow": -9414000, "free_cashflow": -6207125, "price": 0.3419, "52w_high": 5.55, "52w_low": 0.27, "avg_volume": 380810, "avg_volume_10d": 1503510, "full_time_employees": 6, "audit_risk": 0, "overall_risk": 0}}